Education
About Us
Working with TipRanks
Follow Us
Gain Therapeutics (GANX)
NASDAQ:GANX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 55.18K | $ 140.11K | $ 164.99K | $ 28.88K |
| Gross Profit | $ -84.07K | $ -25.20K | $ 75.94K | $ -7.00M | $ -2.23M |
| Operating Income | $ -20.35M | $ -22.25M | $ -17.78M | $ -13.83M | $ -3.48M |
| EBITDA | $ -19.79M | $ -22.17M | $ -17.78M | $ -13.82M | $ -3.47M |
| Net Income | $ -20.41M | $ -22.27M | $ -17.59M | $ -13.89M | $ -3.58M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.39M | $ 16.79M | $ 20.14M | $ 36.88M | $ 7.49M |
| Total Assets | $ 12.12M | $ 18.61M | $ 24.10M | $ 38.99M | $ 9.60M |
| Total Debt | $ 653.01K | $ 1.03M | $ 1.27M | $ 1.61M | $ 1.26M |
| Net Debt | $ -9.73M | $ -10.77M | $ -6.04M | $ -35.27M | $ -6.23M |
| Total Liabilities | $ 4.78M | $ 6.03M | $ 5.22M | $ 4.17M | $ 3.40M |
| Stockholders' Equity | $ 7.34M | $ 12.58M | $ 18.88M | $ 34.82M | $ 6.20M |
| Cash Flow | |||||
| Free Cash Flow | $ -18.90M | $ -18.88M | $ -14.81M | $ -12.46M | $ -3.26M |
| Operating Cash Flow | $ -18.87M | $ -18.87M | $ -14.69M | $ -12.37M | $ -3.24M |
| Investing Cash Flow | $ 4.98M | $ 10.22M | $ -14.77M | $ -94.21K | $ -20.83K |
| Financing Cash Flow | $ 13.01M | $ 12.64M | $ -78.77K | $ 41.77M | $ 10.49M |